糖尿病ケア機器の世界市場規模、シェア、成長分析：タイプ別、患者ケア環境別、地域別 - 産業予測（2024年～2031年）

世界の糖尿病ケア機器の市場規模は、2022年に28億米ドルと評価され、2023年の32億6,000万米ドルから2031年には109億米ドルに成長し、予測期間中（2024年～2031年）のCAGRは16.3％で成長する見通しです。

国際糖尿病連合（IDF）によると、治療法のない慢性的で生命を脅かす糖尿病はパンデミックレベルに達し、世界で約5億3,700万人の成人が罹患しています。特に、座りがちなライフスタイルに関連した2型糖尿病の有病率の増加は、糖尿病ケア機器の需要を促進すると予想されます。心臓発作、腎不全、切断などの慢性糖尿病合併症は、効果的な管理ソリューションの緊急の必要性を強調しています。世界保健機関（WHO）は、肥満率の上昇や健康意識の低下により、糖尿病は低・中所得国でより一般的になっていると強調しています。認知度向上を目的とした政府のさまざまな取り組みとともに、疾病負担が増加するにつれて、糖尿病ケア機器市場は今後数年間で大きな成長を遂げると予測されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ

糖尿病ケア機器市場規模：タイプ別、CAGR（2024年～2031年）

• 市場概要
• 血糖値モニタリングシステム
  • 自己血糖モニタリングシステム
  • 持続血糖モニタリングシステム
  • テストストリップ/テストペーパー
  • ランセット/穿刺器具
• インスリン投与装置
  • インスリンポンプ
  • インスリンペン
  • インスリンシリンジと針
• 糖尿病管理モバイルアプリケーション

糖尿病ケア機器市場規模：患者ケア環境別、CAGR（2024年～2031年）

• 市場概要
• セルフ/在宅ヘルスケア
• 病院と糖尿病専門クリニック

糖尿病ケア機器市場規模、CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比の比較（2021年～2023年）

主要企業プロファイル

• F. Hoffman-La Roche Ltd.
• Abbott
• Ascensia Diabetes Care Holdings AG
• Dexcom, Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Arkray, Inc.
• Sanofi
• Novo Nordisk A/S
• Terumo Corporation
• Ypsomed
• Sinocare, Inc.
• AgaMatrix Holdings LLC
• SD Biosensor, Inc.
• Microgene Diagnostic Systems Pvt. Ltd.
• Dr. Morepen
• Bionime Corporation
• Rossmax International Ltd.

結論と推奨事項

Global Diabetes Care Devices Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.26 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 16.3% during the forecast period (2024-2031).

Diabetes, a chronic and life-threatening condition with no cure, has reached pandemic levels, affecting approximately 537 million adults globally, according to the International Diabetes Federation (IDF). The growing prevalence, particularly of Type 2 diabetes linked to sedentary lifestyles, is expected to drive demand for diabetes care devices. Chronic diabetes complications, including heart attacks, kidney failure, and amputations, underscore the urgent need for effective management solutions. The World Health Organization highlights that diabetes is more prevalent in low to middle-income countries due to rising obesity rates and limited health awareness. As the disease burden increases, alongside various government initiatives aimed at raising awareness, the diabetes care devices market is anticipated to experience significant growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Care Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Care Devices Market Segmental Analysis

Global Diabetes Care Devices Market is segmented by Type, Patient Care Settings, and region. Based on Type, the market is segmented into Blood glucose monitoring systems, Insulin delivery devices, and Diabetes management mobile applications. Based on Patient Care Settings, the market is segmented into Self/Home Healthcare, and Hospitals & Diabetes Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is witnessing significant growth driven by the increasing prevalence of sedentary lifestyles and the associated rise in diabetes cases. With more individuals diagnosed with Type-2 diabetes due to unhealthy habits, the need for effective management solutions has become critical. According to the International Diabetes Federation, approximately 537 million adults are living with diabetes, which increases the urgency for care devices. Growing awareness among patients, alongside the demand for insulin-delivery systems, is further propelling market expansion. Emerging economies present significant opportunities due to a higher incidence of diabetes among middle and lower-middle-class populations, combined with a rising interest in technological advancements by manufacturers.

Restraints in the Global Diabetes Care Devices Market

The growth of the Global Diabetes Care Devices market is expected to encounter challenges during the forecast period, primarily due to the inaccessibility and low awareness of diabetes management technologies in remote and underdeveloped regions. Many patients in these areas lack access to essential diabetes care devices, which significantly limits market penetration. Additionally, the lengthy registration processes for new devices, coupled with complications surrounding reimbursement, further exacerbate these challenges. Consequently, these factors collectively hinder the overall adoption and growth of diabetes care devices in markets that are already struggling with healthcare access and awareness.

Market Trends of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is experiencing significant growth driven by the rising adoption of self-monitoring blood glucose meters and test strips, alongside increased demand for continuous glucose monitoring (CGM) systems. This trend is particularly pronounced in developing countries, where greater awareness of diabetes management is influencing consumer behavior. Additionally, the WHO highlights the alarming statistic that over 60% of the global population lacks sufficient physical activity, exacerbating the risk of type 2 diabetes associated with increased body weight. As health consciousness continues to grow, market players are poised to capitalize on lucrative opportunities in this expanding sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Diabetes Care Devices Market Size by Type & CAGR (2024-2031)

• Market Overview
• Blood glucose monitoring systems
  • Self-monitoring blood glucose monitoring systems
  • Continuous glucose monitoring systems
  • Test strips/test papers
  • Lancets/lancing devices
• Insulin delivery devices
  • Insulin pumps
  • Insulin pens
  • Insulin syringes and needles
• Diabetes management mobile applications

Global Diabetes Care Devices Market Size by Patient Care Settings & CAGR (2024-2031)

• Market Overview
• Self/Home Healthcare
• Hospitals & Diabetes Specialty Clinics

Global Diabetes Care Devices Market Size & CAGR (2024-2031)

• North America (Type, Patient Care Settings)
  • US
  • Canada
• Europe (Type, Patient Care Settings)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Patient Care Settings)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Patient Care Settings)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patient Care Settings)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffman-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microgene Diagnostic Systems Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Morepen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionime Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation